SM
MNTA

Sabby Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Sabby Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-145,600
Closed -$1.71M – 354
2016
Q2 		$1.57M Sell
145,600
-134,625
-48% -$1.39M 0.08% 125
2016
Q1 		$2.59M Buy
280,225
+130,195
+87% +$1.4M 0.13% 80
2015
Q4 		$2.23M Buy
150,030
+100,000
+200% +$1.67M 0.12% 113
2015
Q3 		$821K Buy
+50,030
New +$1.02M 0.03% 259
2014
Q2 		– Sell
-18,274
Closed -$213K – 297
2014
Q1 		$213K Buy
+18,274
New +$309K 0.01% 206

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Sabby Management's MNTA Position: Q3 2016 in Review

Sabby Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2016, closing a stake of 145,600 shares — an estimated $1.71M sold.

Sabby Management first reported a position in MNTA in Q1 2014 and held it in 5 quarters. The position peaked at $2.59M in Q1 2016. 155 funds tracked by Wall St. Rank hold MNTA as of Q3 2016.

  • Sabby Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
  • Sabby Management sold 145,600 Momenta Pharmaceuticals, Inc. shares in Q3 2016, an estimated $1.71M.
  • Sabby Management first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2014 and held it in 5 quarters.
  • Sabby Management's Momenta Pharmaceuticals, Inc. position peaked at $2.59M in Q1 2016.
  • 155 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2016.

Based on Sabby Management's 13F filing for Q3 2016, filed 14 Nov 2016.